摘要 |
FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to 4-arylpiperazines and 4-arylpiperidines of the formula (I) <EMI ID=0.104 HE=27 WI=75 TI=CHI> where A is N or CH; W is C, SO; R<SP>1</SP>, R - H or C<SB>1-4</SB>-alkyl; n = 0-4; R<SP>3</SP>, R - H, alkyl, OH or taken in common as oxygen present carbonyl-group; R - H, C<SB>1-8</SB>-alkyl, C<SB>1-8</SB>-alkoxy-, nitro-, amino-, C<SB>1-8</SB>-acylamino-group; R - H; R is O, S if W is C; R is O if W is SO (other values see p. 1 of the invention claim) that show inhibitory activity with respect to dopamine-2-receptors. EFFECT: new compounds indicated above, inhibitors of receptors. 35 cl, 8 tbl, 113 ex
|